For the quarter ending 2026-03-31, ANTX has $87,491K in assets. $5,732K in debts. $53,487K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 53,487 | 19,941 | 18,003 | 18,220 |
| Short-term investments | 31,801 | 38,060 | 43,918 | 44,696 |
| Prepaid expenses and other current assets | 2,203 | 1,936 | 2,095 | 4,608 |
| Total current assets | 87,491 | 59,937 | 64,016 | 67,524 |
| Other assets, long-term | - | 0 | 0 | 0 |
| Long-term investments | 0 | 2,013 | 3,219 | 8,301 |
| Total assets | 87,491 | 61,950 | 67,235 | 75,825 |
| Accounts payable | 2,615 | 3,021 | 2,226 | 2,113 |
| Accrued compensation | 613 | 2,418 | 1,744 | 1,199 |
| Accrued liabilities | 1,767 | 2,052 | 2,705 | 2,954 |
| Other current liabilities | 567 | 1,229 | 183 | 717 |
| Total current liabilities | 5,562 | 8,720 | - | - |
| Other non-current liabilities | 170 | 170 | - | - |
| Total liabilities | 5,732 | 8,890 | 6,858 | 6,983 |
| Additional paid-in capital | 332,742 | 293,953 | 292,553 | 291,704 |
| Accumulated other comprehensive (loss) gain | -5 | 57 | 64 | 25 |
| Accumulated deficit | -250,978 | -240,950 | -232,240 | -222,887 |
| Total stockholders' equity | 81,759 | 53,060 | 60,377 | 68,842 |
| Total liabilities and stockholders' equity | 87,491 | 61,950 | 67,235 | 75,825 |
AN2 Therapeutics, Inc. (ANTX)
AN2 Therapeutics, Inc. (ANTX)